 The shares of Eli Lilly And Co NYSE:LLY are up 1.9 at 160.83 at last check, after the pharmaceutical giant said it would buy Prevail Therapeutics PRVL for 1.04 billion, in an effort to expand its presence in the lucrative field of gene therapy. 